Azathioprine in inflammatory bowel disease, a safe alternative?

被引：20
|
作者：
Tanis, AA [1 ]
机构：
[1] Erasmus Univ, Hosp Dijkzigt, Dept Gastroenterol & Hepatol, NL-3015 GD Rotterdam, Netherlands
来源：
MEDIATORS OF INFLAMMATION | 1998年 / 7卷 / 03期
关键词：
azathioprine; 6-mercaptopurine; inflammatory bowel disease; bone marrow suppression; side effects; pregnancy;
D O I：
10.1080/09629359891045
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
AZATHIOPRINE and its metabolite 6-mercaptopurine are effective in the treatment of inflammatory bowel disease. They are mostly used for reduction of the use of steroids, maintenance therapy after remission induction by cyclosporin and treatment of fistulae in Crohn's disease. Adverse effects occur in about 15% of patients. The main side effects are pancreatitis, allergic reactions, fever and bone marrow suppression. Symptoms, management and prevention are discussed. A blood monitoring schedule is suggested. Azathioprine and 6-mercaptopurine seem to be safe in pregnancy. There may be a slight increased risk for developing a non-Hodgkin's lymphoma.
引用
收藏
页码：141 / 144
页数：4
相关论文
共 50 条
  • [31] Azathioprine in paediatric inflammatory bowel disease: an Italian multicentre survey
    Barabino, A
    Torrente, F
    Ventura, A
    Cucchiara, S
    Castro, M
    Barbera, C
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (06) : 1125 - 1130
  • [32] Use of azathioprine in inflammatory bowel disease in a district general hospital
    Neild, PJ
    Ainsworth, A
    Leckenby, C
    Mc Intyre, PB
    [J]. GUT, 1999, 44 : A12 - A12
  • [33] PREGNANCY IN INFLAMMATORY BOWEL-DISEASE (IBD) PATIENTS ON AZATHIOPRINE
    ALSTEAD, EM
    RITCHIE, J
    LENNARDJONES, J
    FARTHING, MJG
    CLARK, ML
    [J]. GUT, 1989, 30 (05) : A718 - A718
  • [34] Lower Lymphocyte Counts and Azathioprine Efficacy in Inflammatory Bowel Disease
    Subramaniam, Sharmilla
    Hawkey, Chris J.
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S687 - S687
  • [35] A Case of Inflammatory Bowel Disease and a Rare Lymphoma on Azathioprine Therapy
    Elden, Andrew C.
    Polanco, Nathalie A. Pena
    Vitolo, Melissa
    Hoffman, James E.
    Moshiree, Baharak
    Levy, Cynthia
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S828 - S829
  • [36] Asian experience of azathioprine treatment in inflammatory bowel disease patients
    Thia, T. J. K.
    Ling, K. L.
    Ooi, C. J.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A198 - A198
  • [37] Treatment of inflammatory bowel disease with azathioprine: how to use it in 1999
    Louis, E
    Belaiche, J
    [J]. ACTA GASTRO-ENTEROLOGICA BELGICA, 1999, 62 (04) : 437 - 439
  • [38] Azathioprine: an update on clinical efficacy and safety in inflammatory bowel disease
    Lamers, CBHW
    Griffioen, G
    van Hogezand, RA
    Veenendaal, RA
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1999, 34 : 111 - 115
  • [39] CANCER RISK FROM AZATHIOPRINE IN INFLAMMATORY BOWEL-DISEASE
    CONNELL, WR
    KINLEN, LJ
    RITCHIE, JK
    BALKWILL, A
    LENNARDJONES, JE
    KAMM, MA
    [J]. GASTROENTEROLOGY, 1994, 106 (04) : A667 - A667
  • [40] Adverse effects of azathioprine in patients with inflammatory bowel disease (IBD)
    Ramirez de la Piscina, P.
    Estrada, S.
    Duca, I.
    Spicakova, K.
    Ganchegui, I.
    Calderon, M. D. R.
    Campos, A.
    Salvador, M.
    Delgado, E.
    Lopez Barbarin, J. M.
    Garcia Campos, F.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S309 - S309
12345